Lymphocyte blastogenic responses in sickle cell disease

S Taylor1, S Shacks, S Villicana

  • 1Department of Pediatrics, Charles R. Drew University of Medicine and Science, King/Drew Medical Center, Los Angeles, California 90059.

Insights

Sickle cell disease (SCD) patients in crisis show significantly impaired cell-mediated immunity, with reduced lymphocyte blastogenic responses to mitogens like phytohemagglutinin (PHA) and antigens. This immune dysfunction is particularly pronounced during crisis, especially when infection is present.

Area of Science:

  • Immunology
  • Hematology

Background:

  • Cell-mediated immunity (CMI) in sickle cell disease (SCD) remains under-investigated.
  • Understanding immune responses in SCD is crucial for managing complications.

Purpose of the Study:

  • To assess lymphocyte blastogenic responses in SCD patients during steady state and crisis.
  • To compare immune function in SCD patients with healthy controls and infected individuals.

Main Methods:

  • Evaluated lymphocyte blastogenic responses using phytohemagglutinin (PHA) and antigens (Candida albicans, Tetanus Toxoid).
  • Studied 62 SCD patients (steady state and crisis), 30 healthy controls, and 10 infected controls.
  • Assessed responses via stimulation index and mean counts per minute.

Main Results:

  • 86% of steady-state SCD patients and 100% of healthy controls showed normal responses.
  • Only 20% of SCD crisis patients exhibited normal blastogenic responses.
  • SCD crisis patients displayed significantly depressed proliferation to PHA (70%) and antigens (55% to Candida, 30% to Tetanus).

Conclusions:

  • The crisis state in SCD profoundly impairs blastogenic responses, particularly to PHA.
  • In vitro antigenic stimulation is also affected, though to a lesser extent than mitogen response.
  • Infection exacerbates immune dysfunction in SCD crisis patients.

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Production of Formed Elements01:34

Production of Formed Elements

Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...